| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.86B | -6.8% |
| Cost of Revenue | $3.02B | -3.8% |
| R&D Expense | $7.0M | +75.0% |
| SG&A Expense | $440.0M | -19.1% |
| Interest Expense | $84.0M | +52.7% |
| Pre-tax Income | -$127.0M | -408.0% |
| Income Tax | $55.0M | +1733.3% |
| Net Income | -$182.0M | -550.0% |
| EPS (Basic) | -$0.89 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $582.0M | +40.2% |
| Accounts Receivable | $630.0M | -9.9% |
| Current Assets | $1.63B | -3.3% |
| Total Assets | $3.57B | -11.5% |
| Current Liabilities | $923.0M | -10.0% |
| Long-term Debt | $1.28B | -7.7% |
| Total Liabilities | $2.51B | -9.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $144.0M | -40.7% |
| Capital Expenditures | $92.0M | +15.0% |
| Investing Cash Flow | $173.0M | +221.8% |
| Financing Cash Flow | -$131.0M | +0.8% |
| Free Cash Flow | $52.0M | -68.1% |
| -394.4% |
| EPS (Diluted) | -$0.89 | -394.4% |
| Stockholders' Equity |
| $917.0M |
| -19.0% |